South Korea · Delayed Price · Currency is KRW Genoray Statistics
Total Valuation
Genoray has a market cap or net worth of KRW 40.57 billion. The enterprise value is 55.07 billion.
| Market Cap | 40.57B |
| Enterprise Value | 55.07B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Genoray has 12.15 million shares outstanding. The number of shares has decreased by -7.07% in one year.
| Current Share Class | 12.15M |
| Shares Outstanding | 12.15M |
| Shares Change (YoY) | -7.07% |
| Shares Change (QoQ) | +3.47% |
| Owned by Insiders (%) | 32.21% |
| Owned by Institutions (%) | 0.03% |
| Float | 8.14M |
Valuation Ratios
The trailing PE ratio is 186.40.
| PE Ratio | 186.40 |
| Forward PE | n/a |
| PS Ratio | 0.37 |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | 4.72 |
| P/OCF Ratio | 4.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.17, with an EV/FCF ratio of 6.41.
| EV / Earnings | 250.51 |
| EV / Sales | 0.51 |
| EV / EBITDA | 8.17 |
| EV / EBIT | n/a |
| EV / FCF | 6.41 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.94 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 5.52 |
| Debt / FCF | 4.33 |
| Interest Coverage | -1.69 |
Financial Efficiency
Return on equity (ROE) is 0.13% and return on invested capital (ROIC) is -1.91%.
| Return on Equity (ROE) | 0.13% |
| Return on Assets (ROA) | -0.90% |
| Return on Invested Capital (ROIC) | -1.91% |
| Return on Capital Employed (ROCE) | -2.04% |
| Weighted Average Cost of Capital (WACC) | 4.12% |
| Revenue Per Employee | 300.75M |
| Profits Per Employee | 610,630 |
| Employee Count | 360 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 1.45 |
Taxes
| Income Tax | -1.65B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.11% in the last 52 weeks. The beta is 0.27, so Genoray's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -42.11% |
| 50-Day Moving Average | 4,307.00 |
| 200-Day Moving Average | 4,516.68 |
| Relative Strength Index (RSI) | 27.81 |
| Average Volume (20 Days) | 27,077 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genoray had revenue of KRW 108.27 billion and earned 219.83 million in profits. Earnings per share was 17.92.
| Revenue | 108.27B |
| Gross Profit | 40.84B |
| Operating Income | -1.90B |
| Pretax Income | -1.55B |
| Net Income | 219.83M |
| EBITDA | 6.74B |
| EBIT | -1.90B |
| Earnings Per Share (EPS) | 17.92 |
Balance Sheet
The company has 21.94 billion in cash and 37.20 billion in debt, with a net cash position of -15.26 billion or -1,256.31 per share.
| Cash & Cash Equivalents | 21.94B |
| Total Debt | 37.20B |
| Net Cash | -15.26B |
| Net Cash Per Share | -1,256.31 |
| Equity (Book Value) | 82.60B |
| Book Value Per Share | 6,548.10 |
| Working Capital | 40.65B |
Cash Flow
In the last 12 months, operating cash flow was 9.48 billion and capital expenditures -878.59 million, giving a free cash flow of 8.60 billion.
| Operating Cash Flow | 9.48B |
| Capital Expenditures | -878.59M |
| Depreciation & Amortization | 8.64B |
| Net Borrowing | 4.77B |
| Free Cash Flow | 8.60B |
| FCF Per Share | 707.73 |
Margins
Gross margin is 37.72%, with operating and profit margins of -1.75% and 0.20%.
| Gross Margin | 37.72% |
| Operating Margin | -1.75% |
| Pretax Margin | -1.43% |
| Profit Margin | 0.20% |
| EBITDA Margin | 6.22% |
| EBIT Margin | -1.75% |
| FCF Margin | 7.94% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 4.49%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 4.49% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 1,020.46% |
| Buyback Yield | 7.07% |
| Shareholder Yield | 11.56% |
| Earnings Yield | 0.54% |
| FCF Yield | 21.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 21, 2020. It was a forward split with a ratio of 3.
| Last Split Date | Feb 21, 2020 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
Genoray has an Altman Z-Score of 2.58 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.58 |
| Piotroski F-Score | 4 |